Abstract

HE@Cam are happy to welcome you to a talk by Dr Michael Laxy, the Institute of Health Economics and Health Care Management (Helmholtz Zentrum München).

Randomized trials have shown that lifestyle interventions are effective in preventing type 2 diabetes and with the National Diabetes Prevention Program those lifestyle interventions have been implemented on a large scale in the United States. By using a decision analytic model framework and best available data, this seminar aims to analyze the expected long-term costs and health gains of paying for lifestyle intervention programs in the Medicaid population. Results will be presented from both, a health care system and a narrow Medicaid perspective.

Time: 15:00-16:00, Monday May 20th, 2019 Venue: Large seminar Room, Institute of Public Health, Cambridge

All welcome. Part of the HE@Cam seminars 2018/19 series.

For any questions, please contact healtheconomics@medschl.cam.ac.uk

Michael Laxy: Dr Michael Laxy leads an interdisciplinary team focusing on economic evaluations of prevention and treatment strategies for cardio-metabolic diseases, and the analysis of health policies targeting patient health behavior and quality of care. He is a co-investigator on the population-based KORA research platform in Southern Germany. From 2017-2018 Laxy was a Harkness/B. Braun Fellow in Health Care Policy and Practice at the Centers of Disease Control and Prevention – Division of Diabetes Translation and the Emory University –Global Diabetes Research Center where he analyzed the cost-effectiveness of lifestyle-based diabetes prevention strategies.